Search Results - "HRABETA, JAN"
-
1
Histone Deacetylase Inhibitors as Anticancer Drugs
Published in International journal of molecular sciences (01-07-2017)“…Carcinogenesis cannot be explained only by genetic alterations, but also involves epigenetic processes. Modification of histones by acetylation plays a key…”
Get full text
Journal Article -
2
Drug Sequestration in Lysosomes as One of the Mechanisms of Chemoresistance of Cancer Cells and the Possibilities of Its Inhibition
Published in International journal of molecular sciences (20-06-2020)“…Resistance to chemotherapeutics and targeted drugs is one of the main problems in successful cancer therapy. Various mechanisms have been identified to…”
Get full text
Journal Article -
3
Hypoxia-induced chemoresistance in cancer cells: The role of not only HIF-1
Published in Biomedical papers of the Medical Faculty of the University Palacký, Olomouc, Czechoslovakia (01-06-2015)“…The aim of this review is to provide the information about molecular basis of hypoxia-induced chemoresistance, focusing on the possibility of diagnostic and…”
Get full text
Journal Article -
4
Valproic Acid Increases CD133 Positive Cells that Show Low Sensitivity to Cytostatics in Neuroblastoma
Published in PloS one (14-09-2016)“…Valproic acid (VPA) is a well-known antiepileptic drug that exhibits antitumor activities through its action as a histone deacetylase inhibitor. CD133 is…”
Get full text
Journal Article -
5
Anthracyclines and ellipticines as DNA-damaging anticancer drugs: recent advances
Published in Pharmacology & therapeutics (Oxford) (01-01-2012)“…Over the past forty years, anthracyclines and ellipticines have attracted attention as promising cytostatics. In this review, we focus on their mechanisms of…”
Get full text
Journal Article -
6
Nanodrugs used in cancer therapy
Published in Biomedical papers of the Medical Faculty of the University Palacký, Olomouc, Czechoslovakia (01-06-2019)“…Cancer despite the introduction of new targeted therapy remains for many patients a fatal disease. Nanotechnology in cancer medicine has emerged as a promising…”
Get full text
Journal Article -
7
Apoferritin/Vandetanib Association Is Long-Term Stable But Does Not Improve Pharmacological Properties of Vandetanib
Published in International journal of molecular sciences (20-04-2021)“…A tyrosine kinase inhibitor, vandetanib (Van), is an anticancer drug affecting the signaling of VEGFR, EGFR and RET protooncogenes. Van is primarily used for…”
Get full text
Journal Article -
8
MIAT Is an Upstream Regulator of NMYC and the Disruption of the MIAT/NMYC Axis Induces Cell Death in NMYC Amplified Neuroblastoma Cell Lines
Published in International journal of molecular sciences (25-03-2021)“…Neuroblastoma (NBL) is the most common extracranial childhood malignant tumor and represents a major cause of cancer-related deaths in infants. amplification…”
Get full text
Journal Article -
9
Metallothioneins and cancer
Published in Current protein & peptide science (01-08-2009)“…Metallothioneins (MTs) are low molecular, cysteine-rich proteins that have naturally-occurring Zn(2+) in both clusters. They may serve as a reservoir of metals…”
Get more information
Journal Article -
10
Metallothioneins and zinc in cancer diagnosis and therapy
Published in Drug metabolism reviews (01-12-2012)“…Metallothioneins (MTs) are involved in protection against oxidative stress (OS) and toxic metals and they participate in zinc metabolism and its homeostasis…”
Get full text
Journal Article -
11
Overcoming multidrug resistance in Dox-resistant neuroblastoma cell lines via treatment with HPMA copolymer conjugates containing anthracyclines and P-gp inhibitors
Published in Journal of controlled release (10-07-2016)“…Water-soluble N-(2-hydroxypropyl)methacrylamide copolymer conjugates bearing the anticancer drugs doxorubicin (Dox) or pirarubicin (THP), P-gp inhibitors…”
Get full text
Journal Article -
12
Ellipticine-loaded apoferritin nanocarrier retains DNA adduct-based cytochrome P450-facilitated toxicity in neuroblastoma cells
Published in Toxicology (Amsterdam) (01-05-2019)“…Although ellipticine (Elli) is an efficient anticancer agent, it exerts several adverse effects. One approach to decrease the adverse effects of drugs is their…”
Get full text
Journal Article -
13
Histone deacetylase inhibitors in cancer therapy. A review
Published in Biomedical papers of the Medical Faculty of the University Palacký, Olomouc, Czechoslovakia (23-06-2014)“…Despite recent success toward discovery of more effective anticancer drugs, chemoresistance remains a major cause of treatment failure. There is emerging…”
Get full text
Journal Article -
14
The Histone Deacetylase Inhibitor Valproic Acid Exerts a Synergistic Cytotoxicity with the DNA-Damaging Drug Ellipticine in Neuroblastoma Cells
Published in International journal of molecular sciences (05-01-2018)“…Neuroblastoma (NBL) originates from undifferentiated cells of the sympathetic nervous system. Chemotherapy is judged to be suitable for successful treatment of…”
Get full text
Journal Article -
15
Metal Containing Cytostatics and Their Interaction with Cellular Thiol Compounds Causing Chemoresistance
Published in Anti-cancer agents in medicinal chemistry (01-06-2016)“…The history of metal based cytostatics began in the 1970s by discovering the effects of cisplatin. Since then several generations of platinum based cytostatics…”
Get more information
Journal Article -
16
Multilayered Polyurethane/Poly(vinyl alcohol) Nanofibrous Mats for Local Topotecan Delivery as a Potential Retinoblastoma Treatment
Published in Pharmaceutics (03-05-2023)“…Local chemotherapy using polymer drug delivery systems has the potential to treat some cancers, including intraocular retinoblastoma, which is difficult to…”
Get full text
Journal Article -
17
The mechanism of cytotoxicity and DNA adduct formation by the anticancer drug ellipticine in human neuroblastoma cells
Published in Biochemical pharmacology (01-05-2009)“…The plant constituent ellipticine forms DNA adducts detectable by 32P-postlabeling in the neuroblastoma cell line IMR-32. Adduct levels correlate with…”
Get full text
Journal Article -
18
Hypoxia-mediated histone acetylation and expression of N-myc transcription factor dictate aggressiveness of neuroblastoma cells
Published in Oncology reports (01-04-2014)“…Cells of solid malignancies generally adapt to entire lack of oxygen. Hypoxia induces the expression of several genes, which allows the cells to survive. For…”
Get full text
Journal Article -
19
VPA does not enhance platinum binding to DNA in cisplatin-resistant neuroblastoma cancer cells
Published in Tumor biology (01-09-2017)“…Neuroblastoma represents a malignancy of the sympathetic nervous system characteristic by biological heterogeneity. Thus, chemotherapy exhibits only low…”
Get full text
Journal Article -
20
Valproic acid overcomes hypoxia-induced resistance to apoptosis
Published in Oncology reports (01-04-2012)“…Valproic acid (VPA), a histone deacetylase inhibitor (HDACi), has been shown to be an effective tool in cancer treatment. Although its ability to induce…”
Get full text
Journal Article